BI
IBBQ icon

Beckerman Institutional’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Beckerman Institutional’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$320K Buy
11,030
+265
+2% +$7.71K 0.17% 101
2025
Q4 		$306K Buy
10,765
+166
+2% +$4.52K 0.17% 104
2025
Q3 		$258K Buy
+10,599
New +$244K 0.15% 104

Other funds holding IBBQ

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $68.8M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Beckerman Institutional's IBBQ Position: Q1 2026 in Review

Beckerman Institutional increased its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 2.5% in Q1 2026, buying an estimated $7.71K and bringing the position to 11,030 shares worth $320K. The position accounts for 0.17% of the portfolio, ranked #101.

Beckerman Institutional first reported a position in IBBQ in Q3 2025 and has held it in 3 quarters since. 39 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Beckerman Institutional held 11,030 shares of Invesco NASDAQ Biotechnology ETF worth $320K as of Q1 2026.
  • Beckerman Institutional bought 265 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $7.71K.
  • Invesco NASDAQ Biotechnology ETF made up 0.17% of Beckerman Institutional's portfolio in Q1 2026, its #101 holding.
  • Beckerman Institutional first reported a position in Invesco NASDAQ Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
  • 39 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Beckerman Institutional's 13F filing for Q1 2026, filed 4 May 2026.